Bio-Path Holdings, Inc. (BPTH) is a biopharmaceutical company focused on developing drug candidates for the treatment of various types of cancer. Its main therapeutic platform includes liposomal delivery technology, which enables targeted delivery of therapeutic agents directly to cancer cells. The company primarily focuses on treating leukemia and various types of carcinomas, including breast, pancreatic, and lung cancers. Bio-Path Holdings conducts clinical trials and research to assess the efficacy of its drug candidates and their potential therapeutic benefits. Shares of Bio-Path Holdings, Inc. (BPTH) may be suitable for investors seeking opportunities in the biotechnology sector with a focus on innovative approaches to combating cancer.